LYM D
- Product NDC
- 43857-0401
- Requested package NDC
- 43857-0401-1
- 11-digit product format
- 438570401
- Labeler code
- 43857
- Product ID
- 43857-0401_cb074d46-85dd-411a-bea6-fa62a21045ff
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Chelidonium Majus, Echinacea (Angustifolia), Nasturtium Aquaticum, Taraxacum Officinale, Trifolium Pratense, Urtica Dioica, Hydrastis Canadensis, Thymus (Suis), Thyroidinum (Suis), Arsenicum Album, Coccus Cacti, Lycopodium Clavatum, Phosphorus, Rhus Tox, Borrelia Burgdorferi Nosode, Ledum Palustre
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- BioActive Nutritional, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2016-06-27
- Marketing end
- 2025-02-24
- Substance
- ARSENIC TRIOXIDE; BORRELIA BURGDORFERI; CHELIDONIUM MAJUS; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; LEDUM PALUSTRE TWIG; LYCOPODIUM CLAVATUM SPORE; NASTURTIUM OFFICINALE; PHOSPHORUS; PROTORTONIA CACTI; SUS SCROFA THYMUS; SUS SCROFA THYROID; TARAXACUM OFFICINALE; TOXICODENDRON PUBESCENS LEAF; TRIFOLIUM PRATENSE FLOWER; URTICA DIOICA
- Active strength
- 12 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 43857-0401 | 43857-0401-1 | D | Discontinued by firm | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 43857-0401-1 | 43857040101 | 30 mL in 1 BOTTLE, DROPPER (43857-0401-1) | 30 ml | 2016-06-27 | 2025-02-24 | No | No | Current |